Akouos is a precision genetic medicine company focused on developing gene therapies aimed at restoring, improving, and preserving hearing. As a wholly owned subsidiary of Eli Lilly and Company, Akouos leverages adeno-associated viral (AAV) vector-based gene therapy to address inner ear disorders.
Focus Areas
Notable Investments
